ADMA BIOLOGICS, INC. (ADMA)

Data as of Jul 29, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch ADMA

See up to 3 months of ADMA. The 7-day demo opens the 1M and 3M ranges and puts ADMA on your watchlist.

Latest ADMA insider trades

Jerrold B. Grossman
Open-market purchase$51K
May 27, 2026
Jerrold B. Grossman

About ADMA BIOLOGICS, INC. (ADMA)

The SEC lists ADMA BIOLOGICS, INC. under CIK 0001368514, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for ADMA on EDGAR

ADMA Form 4 activity by transaction type, last 90 days

No Form 4 activity for ADMA in the last 90 days.

ADMA insider transactions (Form 4)

39 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.

Traded	Insider	Transaction	Security	Shares	Price	Value
Jul 24, 2026	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	3,177^{footnote F1}	$8.37	$27K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon the non-reportable vesting and settlement of restricted stock units ("RSUs"). This is not an open market sale of securities.
Jul 16, 2026	Terry Kohler - Officer	Grant or award	Common Stock	85,130^{footnote F1}	$0.00	-
Jul 16, 2026	Terry Kohler - Officer	Grant or award	Stock Option (Right to Buy)	136,363	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued… Full note on SEC EDGAR
May 27, 2026	Jerrold B. Grossman	Open-market purchase	Common Stock	6,400	$7.91	$51K
May 12, 2026	Jerrold B. Grossman	Open-market purchase	Common Stock	12,500	$8.01	$100K
May 11, 2026	Jerrold B. Grossman	Open-market purchase	Common Stock	12,500	$8.01	$100K
Apr 1, 2026	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	20,362^{footnote F1}	$9.11	$185K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Mar 13, 2026	Lawrence P. Guiheen	Option exercise	Common Stock	30,000	$3.66	$110K
Mar 17, 2026	Lawrence P. Guiheen	Gift	Common Stock	30,000	$0.00	-
Mar 17, 2026	Lawrence P. Guiheen	Gift	Common Stock	30,000	$0.00	-
Mar 13, 2026	Lawrence P. Guiheen	Option exercise	Stock Option (Right to Buy)	30,000^{footnote F5}	$0.00	-
Footnote F5 (shares): The Reporting Person is exercising this option due, in part, to its near-term expiration date.
Mar 16, 2026	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000^{footnote F1}	$5.40	$81K
Mar 16, 2026	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000^{footnote F1}	$15.16^{footnote F2}	$227K
Mar 16, 2026	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000^{footnote F1}	$15.16^{footnote F2}	$91K
Mar 16, 2026	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025. Footnote F2 (price): The price reported in Column 4 is the price at which the shares were sold.
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Stock Option (right to buy)	2,175	$0.00	-
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	2,500	$5.00	$13K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	1,250	$4.31	$5K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	2,646	$2.83	$7K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	1,525	$2.35	$4K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	2,175	$1.55	$3K
Mar 6, 2026	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	10,059^{footnote F1}	$15.39	$155K
Mar 7, 2026	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	4,235^{footnote F1}	$15.39	$65K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Other	Common Stock	91,266	$0.00	-
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Open-market sale	Common Stock	10,096^{footnote F3}	$15.63^{footnote F4}	$158K
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Stock Option (right to buy)	2,500	$0.00	-
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Stock Option (right to buy)	1,250	$0.00	-
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Stock Option (right to buy)	2,646	$0.00	-
Mar 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Stock Option (right to buy)	1,525	$0.00	-
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities. Footnote F3 (shares): The securities were sold by the Reporting Person in accordance with the terms of the Divorce Settlement. Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.59 to $15.65, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Mar 6, 2026	Adam S. Grossman - Officer	Tax withholding / forfeiture	Common Stock	56,438^{footnote F1}	$15.39	$869K
Mar 7, 2026	Adam S. Grossman - Officer	Tax withholding / forfeiture	Common Stock	29,513^{footnote F1}	$15.39	$454K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Mar 5, 2026	Steve Elms	Open-market purchase	Common Stock	7,000^{footnote F1,F2}	$15.67	$110K
Mar 6, 2026	Steve Elms	Open-market purchase	Common Stock	7,000^{footnote F2,F4}	$15.39	$108K
Footnote F1 (shares): The reported transaction reflects the open market purchase of shares of ADMA Biologics, Inc. (the "Issuer") common stock. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.58 to $15.74… Full note on SEC EDGAR Footnote F2 (shares): The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes… Full note on SEC EDGAR Footnote F4 (shares): The reported transaction reflects the open market purchase of shares of the Issuer's common stock. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.35 to $15.42, inclusive.
Feb 26, 2026	Adam S. Grossman - Officer	Tax withholding / forfeiture	Common Stock	54,858^{footnote F1}	$15.18	$833K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Feb 19, 2026	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	8,161^{footnote F1}	$16.32	$133K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Feb 19, 2026	Adam S. Grossman - Officer	Tax withholding / forfeiture	Common Stock	24,793^{footnote F1}	$16.32	$405K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Feb 19, 2026	Brad L. Tade - Officer	Tax withholding / forfeiture	Common Stock	6,479^{footnote F1}	$16.32	$106K
Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
Feb 17, 2026	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000^{footnote F1}	$5.40	$81K
Feb 17, 2026	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000^{footnote F1}	$16.08^{footnote F2}	$241K
Feb 17, 2026	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000^{footnote F1}	$16.08^{footnote F2}	$96K
Feb 17, 2026	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025. Footnote F2 (price): The price reported in Column 4 is the price at which the shares were sold.
Feb 9, 2026	Jerrold B. Grossman	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Jerrold B. Grossman	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Feb 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Grant or award	Common Stock	91,631^{footnote F1}	$0.00	-
Feb 9, 2026	Kaitlin M. Kestenberg-Messina - Officer	Grant or award	Stock Option (right to buy)	144,230	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued… Full note on SEC EDGAR
Feb 9, 2026	Adam S. Grossman - Officer	Grant or award	Common Stock	282,529^{footnote F1}	$0.00	-
Feb 9, 2026	Adam S. Grossman - Officer	Grant or award	Stock Option (right to buy)	444,711	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued… Full note on SEC EDGAR
Feb 9, 2026	Young Kwon	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Young Kwon	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Feb 9, 2026	Alison Cecily Finger	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Alison Cecily Finger	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Feb 9, 2026	Eduardo Rene Salas	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Eduardo Rene Salas	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Feb 9, 2026	Lawrence P. Guiheen	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Lawrence P. Guiheen	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Feb 9, 2026	Steve Elms	Grant or award	Common Stock	10,690^{footnote F1}	$0.00	-
Feb 9, 2026	Steve Elms	Grant or award	Stock Option (Right to Buy)	17,730	$0.00	-
Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as… Full note on SEC EDGAR
Dec 15, 2025	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000^{footnote F1}	$5.40	$81K
Dec 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000^{footnote F1}	$19.79^{footnote F2}	$297K
Dec 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000^{footnote F1}	$19.79^{footnote F2}	$119K
Dec 15, 2025	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer. Footnote F2 (price): The price reported in Column 4 is the price at which the shares were sold.
Nov 19, 2025	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000^{footnote F1}	$5.40	$81K
Nov 19, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000^{footnote F1}	$16.00^{footnote F2}	$240K
Nov 19, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000^{footnote F1}	$16.00^{footnote F2}	$96K
Nov 19, 2025	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer. Footnote F2 (price): The price reported in Column 4 is the price at which the shares were sold.
Oct 24, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000^{footnote F1}	$16.00^{footnote F2}	$240K
Oct 24, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000^{footnote F1}	$16.00^{footnote F2}	$96K
Oct 24, 2025	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000^{footnote F1}	$0.00	-
Oct 24, 2025	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000^{footnote F1}	$5.40	$81K
Footnote F1 (shares): Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer. Footnote F2 (price): The price reported in Column 4 is the price at which the shares were sold.
Sep 15, 2025	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000	$5.40	$81K
Sep 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000	$16.13	$242K
Sep 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000	$16.13	$97K
Sep 15, 2025	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000	$0.00	-
Aug 15, 2025	Adam S. Grossman - Officer	Option exercise	Common Stock	15,000	$5.40	$81K
Aug 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	15,000	$16.88	$253K
Aug 15, 2025	Adam S. Grossman - Officer	Open-market sale	Common Stock	6,000	$16.88	$101K
Aug 15, 2025	Adam S. Grossman - Officer	Option exercise	Stock Option (right to buy)	15,000	$0.00	-
Jul 30, 2025	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Common Stock	2,500	$8.98	$22K
Jul 30, 2025	Kaitlin M. Kestenberg-Messina - Officer	Tax withholding / forfeiture	Common Stock	1,208	$18.59	$22K
Jul 30, 2025	Kaitlin M. Kestenberg-Messina - Officer	Option exercise	Employee Stock Option (right to buy)	2,500	$0.00	-

Recent ADMA Form 8-K filings

Read ADMA company news

Aug 5, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 2, 2026Item 5.07

Read the filing on SEC EDGAR

May 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

May 4, 2026Item 8.01, 9.01

ADMA insider trading FAQ

What is the latest insider trade for ADMA?

ADMA BIOLOGICS, INC. (ADMA) has filed no insider reports in the last 90 days. The most recent on record is dated 29 July 2026. The full record for ADMA runs to 39 Form 4 filings, the earliest from 2 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying ADMA stock?

No insider purchases of ADMA were filed in the last 90 days. 5 purchases are on record for this company.

How many insiders are selling ADMA stock?

No insider sales of ADMA were filed in the last 90 days. 22 sales are on record for this company.

Where can I see ADMA SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects ADMA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Jul 29, 2026 - Kaitlin M. Kestenberg-Messina view on EDGAR
Jul 18, 2026 - Terry Kohler view on EDGAR
May 28, 2026 - Jerrold B. Grossman view on EDGAR
May 14, 2026 - Jerrold B. Grossman view on EDGAR
May 12, 2026 - Jerrold B. Grossman view on EDGAR
Apr 4, 2026 - Kaitlin M. Kestenberg-Messina view on EDGAR
Mar 18, 2026 - Lawrence P. Guiheen view on EDGAR
Mar 18, 2026 - Adam S. Grossman view on EDGAR
Mar 11, 2026 - Kaitlin M. Kestenberg-Messina view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where ADMA's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow ADMA with a 7-day demo

ADMA on your watchlist
Every ADMA Form 4 filing on record
Up to 3 months of ADMA price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Traded

Insider

Transaction

Security

Price

Value

Jul 24, 2026

Kaitlin M. Kestenberg-Messina - Officer

Tax withholding / forfeiture

Common Stock

3,177^{footnote F1}

$8.37

$27K

Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon the non-reportable vesting and settlement of restricted stock units ("RSUs"). This is not an open market sale of securities.

Jul 16, 2026

Terry Kohler - Officer

Grant or award

Common Stock

85,130^{footnote F1}

$0.00

Jul 16, 2026

Terry Kohler - Officer

Grant or award

Stock Option (Right to Buy)

136,363

$0.00

Footnote F1 (shares): These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued… Full note on SEC EDGAR

May 27, 2026

Jerrold B. Grossman

Open-market purchase

Common Stock

6,400

$7.91

$51K

May 12, 2026

Jerrold B. Grossman

Open-market purchase

Common Stock

12,500

$8.01

$100K

May 11, 2026

Jerrold B. Grossman

Open-market purchase

Common Stock

12,500

$8.01

$100K

Apr 1, 2026

Kaitlin M. Kestenberg-Messina - Officer

Tax withholding / forfeiture

Common Stock

20,362^{footnote F1}

$9.11

$185K

Footnote F1 (shares): Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.

Mar 13, 2026

Lawrence P. Guiheen

Option exercise

Common Stock

30,000

$3.66

$110K

Mar 17, 2026

Lawrence P. Guiheen

Gift

Common Stock

30,000

$0.00

Mar 17, 2026

Lawrence P. Guiheen

Gift

Common Stock

30,000

$0.00

Mar 13, 2026

Lawrence P. Guiheen

Option exercise

Stock Option (Right to Buy)

30,000^{footnote F5}

$0.00

Footnote F5 (shares): The Reporting Person is exercising this option due, in part, to its near-term expiration date.

Mar 16, 2026